tions as the industry seeks to reduce
non-value-added costs. T&C
References
1. www.marketsandmarkets.com/
Market-Reports/high- potency- api-
market-36582475.html
2. www.dcatvci.org/5920-pharma-
industry- faces-slower- growth- chang
ing-business-models
3. w w w.personalizedmedicine
coalition.org / Userfiles/ PMC-Cor
porate/file/Personalized_Medicine_
101_fact-sheet.pdf
4. www2.deloitte.com/content/
dam / Deloitte/global / Documents/
Life-Sciences-Health-Care/gx-lshc-
ls-outlook-2019.pdf
John S. Ross is presi-
dent of Mayne Phar-
ma USA, part of
Mayne Pharma, an
Australia- headquartered
specialty pharmaceuti-
cal company focused on applying drug
delivery expertise to commercialize brand-
ed and generic pharmaceuticals. Mayne
Pharma also provides contract develop-
ment and manufacturing services to more
than 100 clients worldwide through its
CDMO, Metrics Contract Services (252
752 3800, www.metricscontractservices.
com). Ross earned his MBA from the
Ivey School of Business at the Univer-
sity of Western Ontario, from which he
also received a bachelor's degree in math
and statistics. He has more than 25 years
of experience in pharmaceutical indus-
try marketing, sales, manufacturing, dis-
tribution, global sourcing, and supply
chain management.
A
Ackley Machine ......................................... 23
B
Biocaps Enterprises ................................... 20
D
Donaldson Torit ........................................... 1
E
Elizabeth........................................................ 8
Excipient World ......................................... 15
K
Kraemer US................................................. 20
Kuriyama of America ................................ 26
L
Lonza ............................................................. 5
N
Natoli ..................................................Cover 4
Q
Qualicaps....................................................... 7
R
R.W. Hartnett ..............................................14
Recro Gainesville ......................................... 3
S
SMI ............................................................... 19
Suheung Capsule ......................................... 9
T
Techceuticals .............................................. 26
Tri-Star Technologies .......................Cover 2
V
Vac-U-Max .................................................... 6
advertiser index
CONNECT
CONNECT
WITH
Like
Like T&C magazine on Facebook
@TabletsCapsules
Connect
Connect with T&C magazine on LinkedIn
Tablets and Capsules Magazine
Follow
Follow T&C magazine on Twitter
@TabletsCapsules
E-news
Sign up for our newsletter
tabletscapsules.com/solid-dose-digest-newsletter
Magazine
Subscribe to our print or digital edition
tabletscapsules.com/subscription
